S. Korea approves sales of new stem cell drug

January 19, 2012

South Korea's government drug agency cleared the way Thursday for commercial sales of what it called the world's first approved medicine using stem cells collected from other people.

Cartistem, developed by Seoul-based Medipost, will help regenerate knee cartilage using developed from newborns' umbilical cord blood, the Korea said.

"Cartistem is... the world's first approved allogeneic (taken from different individuals of the same species) stem cell drug, that can offer new opportunity for treatment of patients with degenerative arthritis," the administration said in a statement.

Medipost said 27 billion won ($23.8 million) from private investors and had been invested to develop Cartistem since 2001. The drug can be injected into a patient's knees via surgery.

Clinical trials have been under way in the United States since last year, the statement said.

Two of the world's top 10 drugmakers are in talks to seek a worldwide licence to make the drug, a Medipost spokesman told AFP, adding that final trials involving a large number of people would likely begin in the US in 2015.

Explore further: Stem cell scientists share research

Related Stories

Stem cell scientists share research

August 25, 2005

Top researchers into the use of embryonic stem cells gathered at Yonsei University in Seoul Thursday for a two-day symposium to share their findings.

Stem cells to be injected into the heart

August 26, 2005

The University of Pittsburgh Medical Center will begin a clinical trial to determine the feasibility of injecting a patient's own stem cells into the heart.

Calif. institute budgets stem cell funds

October 5, 2006

The California Institute for Regenerative Medicine has decided how to spend the $3 billion approved by the U.S. state's voters for stem cell research.

Stem Cell Research Made Safer with Latest Discovery

May 15, 2009

(PhysOrg.com) -- A new development in stem cell research has resulted from a completed study by a collaboration of scientists using the drug Rapamycin to inhibit mTOR, an intracellular protein necessary in cell proliferation. ...

S. Korea to revive stem cell research after scandal

September 19, 2011

President Lee Myung-Bak promised Monday to spend some $89 million restoring South Korea's reputation as a leader in stem cell research, five years after a scandal tarnished its reputation.

US approves drug for middle-of-the-night insomniacs

November 23, 2011

The US Food and Drug Administration, for the first time, approved Wednesday medication specifically designed for those who wake up in the middle of the night and cannot fall back to sleep.

Recommended for you

Back pain link to 24-hour body clock revealed

August 4, 2016

New research by University of Manchester scientists has for the first time shown that our spinal discs have 24-hour body clocks which when they malfunction, can contribute to lower back pain.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.